Patent ID: 8058281

Claim:
A method for treating systemic lupus erythematosus in a subject in need thereof, comprising administering to said subject an efficient amount of a compound of formula (I) wherein R1 is selected from the group consisting of CF 3 , a C 1 -C 5 alkyl, and (CH 2 ) n R 4 wherein n is between 0 and 4; R2 is selected from the group consisting of (CH 2 ) m R4 and (CH 2 ) m Ar wherein m is between 0 and 5; R3 is selected from the group consisting of hydrogen and methyl; R4 is selected from the group consisting of phenyl, OH, a C 1 -C 3 alkoxy, a C 1 -C 3 dialkylamino, piperidino, and N-methylpiperazino; Ar represents wherein X is selected from the group consisting of F, C1, a C 1 -C 3 alkoxy, and CF 3 ; or of a pharmaceutically acceptable salt, an enantiomer or a diastereoisomer thereof, or a mixture of these.